SpyGlass Pharma cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 2 quarters of results from Jun 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2025 | Jun2026 |
|---|---|---|
| Operating Activities | ||
| Net Income | -8.68M | -19.86M |